The complement system: The driving force behind a new generation of immunotherapies

The complement system: The driving force behind a new generation of immunotherapies

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the complement system is an oft-overlooked part of the immune system that could be exploited to create new therapies.